Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by CancerSlayeron Jan 18, 2022 2:57pm
648 Views
Post# 34329859

RE:Updated Research Page on McFarland Labs Website

RE:Updated Research Page on McFarland Labs Website

Thanks Eoganacht...

Per Dr. McFarland's lab website:

Photobiology
 
"Using the underlying photophysics for rational design of photoactive compounds, we are able to install high levels of activity in either an oxygen-dependent (PDT) or independent (PCT) manner. To confirm their photobiological potency for any given application, we screen several human cancer cell lines across a variety of treatments – including variable oxygen tension (0.1–21% O2), multiple light sources and activation wavelengths from high energy blue (453 nm) to low energy near- infrared (733–976 nm), and manipulation of the light dosimetry (fluence, fluence rate, pulsed or fractioned, bandwidth). Through our application-driven and interdisciplinary approach, we have already successfully identified TLD1433, the first Ru-photosensitizer to undergo clinical trials (Phase II, clinical trial identifier NCT03945162), and continue to push the limits in light-activated therapies."

 
Would like to see TLT capitalize on Dr. McFarland's amazing knowledge in chemistry in the form of a JV between her private company, PhotoDynamic Inc., & TLT (majority partner).  The goal would be to develop nano scintillation tech to allow this superior photosensitizer (PS) to be activated by x-ray.  An interesting solution was presented way back in Nano Letters (3/12/2015) that utilized readily available elements, including an x-ray converting phosphor at the core of a two-layer silica-based structure that contained an outer porous layer loaded with PS.  Perhaps HPQ Silicon Resources could provide the purified silica ; )

The phosphor (i.e. doped Strontium Aluminate) is considered non-toxic/biologically inert & essentially converts x-ray photons into visible photons, a process call x-ray excited optical luminescence (XEOL).  This readily available phosphor converts x-ray photons into peak wavelengths of 520 nm (I.e. green light...sound familiar ; )...this is the precise wavelength that activates TLD-1433.  Such XEOL would add immeasurable value to our current ACT tech imo.  

I'll let the financially savvy here figure out the financing of such invaluable tech.  GLTA...
 


 
<< Previous
Bullboard Posts
Next >>